@article{Millington_T-2023_164901,
title = {Caveats in reporting of national vaccine uptake},
author = {Millington, T. and Morrison, K. and Jeffrey, K. and Sullivan, C. and Kurdi, A. and Fagbamigbe, A. and Swallow, B. and Shi, T. and Shah, S. and Kerr, S. and Simpson, C. and Ritchie, S. and Robertson, C. and Sheikh, S. and Rudan, I.},
month = {dec},
year = {2023},
abstract = {During the work of the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) group, we reported on vaccine uptake, safety, effectiveness, and waning in specific age groups in Scotland (e.g., 12-17 years) to enable policymakers to make decisions based on evidence generated nearly in real-time [1]. At first, these imperatives appeared methodologically straightforward. However, we soon realised that the seemingly simplest task in theory – i.e., reporting the vaccine uptake – was in fact challenging in practice. We report several caveats that need to be considered when reporting vaccine uptake for a specific age-group at a national level. We also propose a simple stepwise approach for reporting the methods of calculating vaccine uptake in a specific age-group in the context of tracking a large population.},
journal = {Journal of Global Health},
publisher = {International Society of Global Health},
url = {https://publichealthscotland.scot/id/164901},
}
